Skip to main content

LEMAITRE VASCULAR INC

For the period ended Sep 30, 2024. Filed Nov 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 8, 2024

LMAT$79.02-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unregistered Sales of Equity Securities and Use of Proceeds

Recent Sales of Unregistered Securities

None.

Issuer Purchases of Equity Securities

Issuer Purchases of Equity Securities
Maximum Number
(or Approximate
Total Number of · Dollar Value) of
Shares (or Units) · Shares (or Units)
Total · Average · Purchased as · that may yet be
Number of · Price · Part of Publicly · Purchased under
Shares (or Units) · Paid Per · Announced Plans · the Plans or
Period · Purchased (1) · Share (or Unit) · or Program · Program
July 1, 2024 through July 31, 2024-$--$-
August 1, 2024 through August 31, 202421$85.36-$-
September 1, 2024 through September 30, 2024-$--$-
Total21$85.36-$-

(1) For the three months ended September 30, 2024, we repurchased 21 shares of our common stock to satisfy employees’ obligations with respect to minimum statutory withholding taxes in connection with the vesting of restricted stock units.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.